使用日本语自发报告数据库对索拉费尼布相关心脏不良事件的不成比例分析
Y Kanbayashi1, R Kano2, E Tsuchiya2
1Department of Education and Research Center for Clinical Pharmacy , Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Die Pharmazie
|April 10, 2025
概括
索拉芬尼的使用与严重的心脏不良事件 (AE) 有关,包括致命的结局,如心力衰竭和心肌梗塞. 在整个治疗过程中,对这些副作用的患者进行监测至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 心脏病学 心脏病学
- 在瘤学瘤学.
背景情况:
- 索拉菲尼布是一种用于癌症治疗的氨酸激酶抑制剂.
- 心脏不良事件 (AEs) 是索拉菲尼布治疗的一个已知的问题.
- 了解特定的心脏风险及其发作对于患者安全至关重要.
研究的目的:
- 通过使用日本不良药事件报告数据库,调查索拉费尼布相关的心脏副作用.
- 分析这些心脏AE的不成比例性,发病时间,发病率和结果.
- 为了确定与索拉费尼布治疗相关的特定心脏安全信号.
主要方法:
- 分析日本药物不良事件报告数据库 (2004年4月 - 2023年5月).
- 从8,374份索拉芬尼相关的AE报告中提取和分析了318个心脏AE.
- 使用报告赔率比率 (RORs) 估计AE不成比例.
- 使用直方图和韦布尔分布评估发病时间和发病率模式.
主要成果:
- 检测到七个心脏AE信号:高血压,充血性心力衰竭,心肌梗塞,急性心肌梗塞,胸痛,心肌缺血和不稳定性胸痛.
- 报告的致命结局是充血性心力衰竭,心肌梗塞,急性心肌梗塞和心肌缺血.
- 发病的中位时间在服用后的9至159天之间.
- 在整个暴露期间 (随机故障类型) 中,AE发生率一直持续.
结论:
- 索拉芬尼与显著的心脏不良事件有关,其中一些具有致命的结果.
- 患者需要对心脏AE进行监测,不仅在治疗的早期,而且在较长时间内进行监测.
- 营销后监测对于了解和管理索拉费尼布的心脏安全概况至关重要.
相关概念视频
01:12Hazard Ratio
72
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
72
01:20Comparing the Survival Analysis of Two or More Groups
92
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
92
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
106
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
01:21Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308